About the clinic
Established in 1939, Institut Jules Bordet is Belgium’s only autonomous medical institution entirely dedicated to cancer care. Located in Brussels, it serves patients from across Europe and beyond, offering a multidisciplinary approach that integrates clinical care, research, and education. As part of the Hôpital Universitaire de Bruxelles (H.U.B.), alongside Erasme Hospital and Queen Fabiola Children’s University Hospital, the institute provides comprehensive services in oncology. It is accredited by the Organisation of European Cancer Institutes (OECI) as a Comprehensive Cancer Centre, a designation awarded only to institutions that meet rigorous standards in patient care, research, and education.
Discover why thousands of patients choose Institut Jules Bordet for world-class cancer treatment abroad.
Key Specialties and Departments
Institut Jules Bordet offers a wide range of specialized departments, each focusing on different aspects of cancer care:
- Medical Oncology: Provides chemotherapy, immunotherapy, and targeted therapies for various cancers, including breast, lung, and gastrointestinal cancers.
- Surgical Oncology: Performs complex surgeries, including robotic-assisted procedures, for solid tumors and soft tissue cancers.
- Radiation Oncology: Utilizes advanced technologies like Elekta Unity MR-Linac for precise radiation therapy, particularly for abdominal and pelvic cancers.
- Hematology and Bone Marrow Transplant: Specializes in the treatment of blood cancers, offering stem cell and bone marrow transplants.
- Supportive and Palliative Care: Provides comprehensive care to manage symptoms and improve the quality of life for patients with advanced cancer.
- Clinical Trials and Research: Engages in cutting-edge research, offering patients access to the latest therapies through participation in international clinical studies.
Advanced Technologies and Facilities
Institut Jules Bordet is at the forefront of medical technology, integrating state-of-the-art equipment and facilities to provide exceptional care:
- 1.5T MRI-Linac: Combines high-field MRI imaging with a linear accelerator, enabling real-time imaging during radiation therapy for precise treatment planning.
- Elekta Unity MR-Linac: A transformative system that allows for personalized precision radiation therapy, particularly beneficial for treating cancers of the abdomen and pelvis.
- Radiotheranostics: Implements molecular radiotherapy techniques, such as Peptide Receptor Radionuclide Therapy (PRRT), for neuroendocrine tumors and Radioligand Therapy (RLT) for prostate cancer.
- Translational Research Facilities: Equipped with genomics and proteomics laboratories, cytometry technology, and multimodal imaging systems to support innovative research initiatives.
- Modern Infrastructure: The institute’s 80,000 m² facility includes 250 hospital beds, 140 day hospital places, and 104 consultation boxes, designed to facilitate integrated and patient-centered care.
